The rise of the phoenix: the expanding role of the eosinophil in health and disease

We have entered a new phase in the evolution of our understanding of the role of the eosinophil with a greater appreciation of novel potential functions that may be ascribed to this enigmatic cell type. This review not only provides an update to our current understanding of the various immunobiological roles for the eosinophil, but also attracts attention to some novel observations predicting functions beyond its putative effector role. These observations include the intriguing possibility that the eosinophil may posses the capacity to regulate the immune and inflammatory responses in diseases such as asthma.

[1]  Paige Lacy,et al.  Eosinophil function in allergic inflammation: From bone marrow to tissue response , 2004, Current allergy and asthma reports.

[2]  J. Boyce,et al.  Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. , 2004, The Journal of allergy and clinical immunology.

[3]  D. Armstrong.  In celebration of expectoration: induced sputum indices as outcome measures in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[4]  J. Ring,et al.  Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. , 2003, The New England journal of medicine.

[5]  W. Busse,et al.  Rhinovirus-induced Interferon-γ and Airway Responsiveness in Asthma , 2003 .

[6]  G. Landman,et al.  Eotaxin expression in oral squamous cell carcinomas with and without tumour associated tissue eosinophilia. , 2003, Oral diseases.

[7]  M. Mäkelä,et al.  Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness. , 2003, The Journal of allergy and clinical immunology.

[8]  H. Hoogsteden,et al.  Airway Eosinophils Accumulate in the Mediastinal Lymph Nodes but Lack Antigen-Presenting Potential for Naive T Cells 1 , 2003, The Journal of Immunology.

[9]  P. Kingham,et al.  Eosinophil-induced release of acetylcholine from differentiated cholinergic nerve cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[10]  Chang Keun Kim,et al.  Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis. , 2003, The Journal of allergy and clinical immunology.

[11]  D. Schwartz,et al.  Allergen-induced airway disease is mouse strain dependent. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[12]  D. Postma,et al.  Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. , 2003, American journal of respiratory and critical care medicine.

[13]  D. Adamko,et al.  The eosinophil as a therapeutic target in asthma: beginning of the end, or end of the beginning? , 2003, Current opinion in pharmacology.

[14]  H. Kita,et al.  Marked Airway Eosinophilia Prevents Development of Airway Hyper-responsiveness During an Allergic Response in IL-5 Transgenic Mice1 , 2003, The Journal of Immunology.

[15]  P. Foster,et al.  Dissociation of T helper type 2 cytokine‐dependent airway lesions from signal transducer and activator of transcription 6 signalling in experimental chronic asthma , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  G. Hershey.  IL-13 receptors and signaling pathways: an evolving web. , 2003, The Journal of allergy and clinical immunology.

[17]  N. Wadhwa,et al.  Eosinophils as a marker for invasion in cervical squamous neoplastic lesions. , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[18]  D. Umetsu,et al.  Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity , 2003, Nature Medicine.

[19]  A. Fryer,et al.  CD8+ T lymphocytes in viral hyperreactivity and M2 muscarinic receptor dysfunction. , 2003, American journal of respiratory and critical care medicine.

[20]  James J. Lee,et al.  A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies , 2003 .

[21]  A. Kay,et al.  Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. , 2003, American journal of respiratory and critical care medicine.

[22]  W. Busse,et al.  Rhinovirus-induced interferon-gamma and airway responsiveness in asthma. , 2003, American journal of respiratory and critical care medicine.

[23]  Lin Ying Liu,et al.  Decreased Expression of Membrane IL-5 Receptor α on Human Eosinophils: I. Loss of Membrane IL-5 Receptor α on Airway Eosinophils and Increased Soluble IL-5 Receptor α in the Airway After Allergen Challenge1 , 2002, The Journal of Immunology.

[24]  Lin Ying Liu,et al.  Decreased Expression of Membrane IL-5 Receptor α on Human Eosinophils: II. IL-5 Down-Modulates Its Receptor Via a Proteinase-Mediated Process1 , 2002, The Journal of Immunology.

[25]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[26]  S. Phipps,et al.  The Relationship Between Allergen-Induced Tissue Eosinophilia and Markers of Repair and Remodeling in Human Atopic Skin1 , 2002, The Journal of Immunology.

[27]  U. Grohmann,et al.  T cell apoptosis by tryptophan catabolism , 2002, Cell Death and Differentiation.

[28]  Paige Lacy,et al.  Human eosinophils express and release IL‐13 following CD28‐dependent activation , 2002, Journal of leukocyte biology.

[29]  L. J. Woods,et al.  Intracrine Cysteinyl Leukotriene Receptor–mediated Signaling of Eosinophil Vesicular Transport–mediated Interleukin-4 Secretion , 2002, The Journal of experimental medicine.

[30]  G. Landman,et al.  Tumour‐associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas , 2002, Histopathology.

[31]  C. Bizer,et al.  Eosinophils Express Functional IL-13 in Eosinophilic Inflammatory Diseases1 , 2002, The Journal of Immunology.

[32]  A. Frew,et al.  Is there more than one inflammatory phenotype in asthma? , 2002, Thorax.

[33]  I. Takanami,et al.  Immunohistochemical detection of eosinophilic infiltration in pulmonary adenocarcinoma. , 2002, Anticancer research.

[34]  I. Pavord,et al.  Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.

[35]  D. Corry,et al.  The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. , 2002, American journal of respiratory cell and molecular biology.

[36]  S. Collins,et al.  Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[37]  R. Flavell,et al.  Transforming growth factor-beta in T-cell biology. , 2002, Nature reviews. Immunology.

[38]  Lin Ying Liu,et al.  Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge. , 2002, Journal of immunology.

[39]  H. Hoogsteden,et al.  Airway inflammation is present during clinical remission of atopic asthma. , 2001, American journal of respiratory and critical care medicine.

[40]  S. Mazzone,et al.  Multiple mechanisms of reflex bronchospasm in guinea pigs. , 2001, Journal of applied physiology.

[41]  R. Geha,et al.  IL-3 Induces B7.2 (CD86) Expression and Costimulatory Activity in Human Eosinophils , 2001, The Journal of Immunology.

[42]  M. Segal,et al.  Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. , 2001, The Journal of allergy and clinical immunology.

[43]  D. Umetsu,et al.  Critical Role for IL-13 in the Development of Allergen-Induced Airway Hyperreactivity1 , 2001, The Journal of Immunology.

[44]  P. Barnes,et al.  Histamine and serotonin. , 2001, Pulmonary pharmacology & therapeutics.

[45]  T. Sandström,et al.  Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma. , 2001, American journal of respiratory and critical care medicine.

[46]  P. Foster,et al.  Eosinophils Promote Allergic Disease of the Lung by Regulating CD4+ Th2 Lymphocyte Function1 , 2001, The Journal of Immunology.

[47]  J. Erjefält,et al.  Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease , 2001, Thorax.

[48]  A. McKenzie,et al.  Elemental signals regulating eosinophil accumulation in the lung , 2001, Immunological reviews.

[49]  K. Chung,et al.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.

[50]  J. Denburg,et al.  Interleukin‐4 and RANTES expression in maturing eosinophils derived from human cord blood CD34+ progenitors , 2000, Immunology.

[51]  P. O'Byrne,et al.  Systemic aspects of allergic disease: bone marrow responses. , 2000, The Journal of allergy and clinical immunology.

[52]  A. Herbelin,et al.  CD11c+ Eosinophils in the Murine Thymus: Developmental Regulation and Recruitment upon MHC Class I-Restricted Thymocyte Deletion , 2000, The Journal of Immunology.

[53]  P. Foster,et al.  Integrated Signals Between IL-13, IL-4, and IL-5 Regulate Airways Hyperreactivity , 2000, The Journal of Immunology.

[54]  M. Sears,et al.  Induced sputum cell counts: their usefulness in clinical practice. , 2000, The European respiratory journal.

[55]  P. Weller,et al.  Lymph node trafficking and antigen presentation by endobronchial eosinophils. , 2000, The Journal of clinical investigation.

[56]  J. Tavernier,et al.  Evidence for Local Eosinophil Differentiation Within Allergic Nasal Mucosa: Inhibition with Soluble IL-5 Receptor1 , 2000, The Journal of Immunology.

[57]  Paige Lacy,et al.  Eosinophil cytokines. , 2000, Chemical immunology.

[58]  G. Gleich,et al.  Ovalbumin Sensitization Changes the Inflammatory Response to Subsequent Parainfluenza Infection , 1999, The Journal of experimental medicine.

[59]  J. Erjefält,et al.  Degranulation in eosinophils in human, but not in mouse, airways , 1999, Allergy.

[60]  A. Capron,et al.  Expression of Cd28 and Cd86 by Human Eosinophils and Role in the Secretion of Type 1 Cytokines (Interleukin 2 and Interferon γ) , 1999, The Journal of experimental medicine.

[61]  G. Russell.  Allergy and Allergic Diseases—The New Mechanisms and Therapeutics, , 1999, Archives of disease in childhood.

[62]  P. Sly,et al.  Muscarinic blockade of methacholine induced airway and parenchymal lung responses in anaesthetised rats , 1999, Thorax.

[63]  J. Denburg.  Bone marrow in atopy and asthma: hematopoietic mechanisms in allergic inflammation. , 1999, Immunology today.

[64]  Y. Qin,et al.  TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma. , 1999, American journal of respiratory and critical care medicine.

[65]  S. Durham,et al.  Granulocyte/Macrophage–Colony Stimulating Factor in Allergen–Induced Rhinitis: Cellular Localization, Relation to Tissue Eosinophilia and Influence of Topical Corticosteroid , 1998, International Archives of Allergy and Immunology.

[66]  R. Garofalo,et al.  Lyn, Jak2, and Raf-1 Kinases Are Critical for the Antiapoptotic Effect of Interleukin 5, whereas only Raf-1 Kinase Is Essential for Eosinophil Activation and Degranulation , 1998, The Journal of experimental medicine.

[67]  A. Fryer,et al.  Virus- and interferon-induced loss of inhibitory M2 muscarinic receptor function and gene expression in cultured airway parasympathetic neurons. , 1998, The Journal of clinical investigation.

[68]  S. Phan,et al.  The role of eosinophils in pulmonary fibrosis (Review). , 1998, International journal of molecular medicine.

[69]  A. Fryer,et al.  Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. , 1997, The Journal of clinical investigation.

[70]  G. Gleich,et al.  Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function. , 1997, The American journal of physiology.

[71]  J. Erjefält,et al.  "Ultimate activation" of eosinophils in vivo: lysis and release of clusters of free eosinophil granules (Cfegs). , 1997, Thorax.

[72]  C. Bachert,et al.  Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. , 1997, Journal of immunology.

[73]  M. Horton,et al.  Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. , 1997, Journal of immunology.

[74]  R. Egan,et al.  Pulmonary biology of anti-interleukin 5 antibodies. , 1997, Memorias do Instituto Oswaldo Cruz.

[75]  Z. Yasruel,et al.  Evidence for major basic protein immunoreactivity and interleukin 5 gene activation during the late phase response in explanted airways. , 1996, American journal of respiratory cell and molecular biology.

[76]  F. Hargreave,et al.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. , 1996, American journal of respiratory and critical care medicine.

[77]  P. MacAry,et al.  Expression of Th‐2 cytokines interleukin‐4 and −5 and of Th‐1 cytokine interferon‐γ in ovalbumin‐exposed sensitized Brown‐Norway rats , 1996, Immunology.

[78]  S. Durham,et al.  Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein , 1996, European journal of immunology.

[79]  P. Foster,et al.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model , 1996, The Journal of experimental medicine.

[80]  S. Durham,et al.  Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. , 1995, Journal of immunology.

[81]  F. Levi-Schaffer,et al.  Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. , 1995, Blood.

[82]  P. Leder,et al.  Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung , 1995, The Journal of experimental medicine.

[83]  A. Wardlaw,et al.  Eosinophils: biology and role in disease. , 1995, Advances in immunology.

[84]  A. Fryer,et al.  The effect of leukocyte depletion on pulmonary M2 muscarinic receptor function in parainfluenza virus‐infected guinea‐pigs , 1994, British journal of pharmacology.

[85]  L. Koenderman,et al.  Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics. , 1994, American journal of respiratory and critical care medicine.

[86]  P. Barnes,et al.  Efficacy and Safety of Inhaled Corticosteroids in Asthma , 1993 .

[87]  A. Wardlaw,et al.  Adhesion to fibronectin prolongs eosinophil survival , 1993, Journal of Experimental Medicine.

[88]  P. Barnes,et al.  Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. , 1993, The American review of respiratory disease.

[89]  C. Sanderson,et al.  Interleukin-5, eosinophils, and disease. , 1992, Blood.

[90]  A. Wardlaw,et al.  Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils , 1991, The Journal of experimental medicine.

[91]  J. Zaagsma,et al.  Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle. , 1990, Pulmonary pharmacology.

[92]  P. Barnes,et al.  Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea pig airways. , 1988, Journal of applied physiology.

[93]  M. Oken,et al.  Leukocytosis and large cell lung cancer. A frequent association , 1987, Cancer.

[94]  R. Callard,et al.  Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays , 1987, European journal of immunology.

[95]  G. Gleich,et al.  The eosinophil and the pathophysiology of asthma. , 1986, The Journal of allergy and clinical immunology.

[96]  G. Gleich,et al.  The eosinophilic leukocyte: structure and function. , 1986, Advances in immunology.

[97]  A. Fryer,et al.  Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea‐pig , 1984, British journal of pharmacology.

[98]  K. E. Holley,et al.  IDENTIFICATION BY IMMUNOFLUORESCENCE OF EOSINOPHIL GRANULE MAJOR BASIC PROTEIN IN LUNG TISSUES OF PATIENTS WITH BRONCHIAL ASTHMA , 1982, The Lancet.

[99]  J. David,et al.  Eosinophil function. , 1981, The New England journal of medicine.

[100]  M. Vadas,et al.  Interactions between human eosinophils and schistosomula of schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence , 1979, The Journal of experimental medicine.

[101]  J. Nadel,et al.  Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. , 1976, The American review of respiratory disease.